Pendulum GLP-1 Probiotic Review 2026: Live Akkermansia, Strong Mechanism, No Product Trial

Which Version Is on Your Shelf?

Pendulum sells a consumer GLP-1 Probiotic and a practitioner version, GLP-1 Probiotic Pro. Retail labels differ slightly: one lists two strains with 211 mg of inulin, others list three strains including Bifidobacterium infantis, with 174 mg or 211 mg of inulin. All list 500 million AFU per capsule. Check the panel on your own bottle.

The Vitacost listing for the consumer product shows a probiotic blend of Clostridium butyricum WB-STR-0006 and Akkermansia muciniphila WB-STR-0001 at 500 million AFU, plus 211 mg of chicory inulin, in a vegetarian hypromellose capsule with microcrystalline cellulose and silica. Practitioner listings for the Pro version show the same two strains plus Bifidobacterium infantis, with some listing 174 mg of inulin and others 211 mg, and a note to refrigerate for optimal quality.

These differences may reflect a reformulation, different production runs or listing errors. They are small, but probiotic buyers should know exactly which strains they are taking, so read the panel when the bottle arrives.

According to Contrary Research's company profile, Pendulum launched the GLP-1 Probiotic in March 2024 at $65, described as a three-strain formula intended to raise the body's own GLP-1 rather than deliver the hormone. The company took the Pendulum name in 2019 and sells several other products, including a single-strain Akkermansia and a five-strain medical food called Glucose Control.

AFU, Not CFU: How Pendulum Counts Bacteria

Most probiotics list colony forming units (CFU), counted by growing bacteria on a plate. Pendulum lists active fluorescent units (AFU), counted by staining cells and measuring them with a flow cytometer. AFU can capture bacteria that are alive but hard to grow in a lab, which matters for an organism like Akkermansia. The two units are not directly comparable.

Five hundred million may look small next to probiotics advertising 50 billion CFU. That comparison misleads in two ways. The units differ, and the strains differ. A large CFU count of common Lactobacillus strains tells you nothing about how many Akkermansia cells a product delivers, because those products contain none.

What matters for a live probiotic is whether the bacteria are alive when you take them. Akkermansia is a strict anaerobe: oxygen kills it. Pendulum's own manufacturing and the instruction to refrigerate are both aimed at keeping the count on the label close to the count in the capsule. Heat, humidity and time all reduce viable bacteria, so storage at home matters too.

The P9 Discovery: Where the GLP-1 Idea Comes From

In a 2021 study, researchers identified a protein named P9 that Akkermansia releases. Purified P9 alone was enough to make gut L-cells release GLP-1 in lab dishes, and it raised GLP-1 secretion in mice fed a high-fat diet. That is the strongest mechanistic link between a single gut bacterium and GLP-1.

The research team found that Akkermansia increased GLP-1 secretion and heat production from brown fat in mice on a high-fat diet. They then traced part of the effect to an 84 kDa protein they named P9 and showed that P9 by itself induced GLP-1 release from L-cells (Yoon et al., 2021).

That matters because GLP-1 comes from L-cells in the gut lining. A review of GLP-1 physiology describes how these cells release the hormone after meals, helping the body release insulin in response to food, slowing stomach emptying and signaling fullness (Holst, 2007). A bacterium that lives on the gut lining and releases a GLP-1-triggering protein is a plausible partner for that system.

The gap is translation. Cells and mice are where mechanisms are found, not where human benefits are confirmed. Natural GLP-1 lasts only minutes in the blood, while prescription GLP-1 drugs are designed to last far longer (Drucker, 2018). Even if Pendulum's strain raises GLP-1 in people, the effect would be on the body's own short-lived hormone, which is a much smaller thing than what a drug does.

Butyrate and Clostridium butyricum

The second strain, Clostridium butyricum, produces butyrate, a short-chain fatty acid. Butyrate acts on a receptor called FFAR2 on L-cells, which helps regulate release of GLP-1 and peptide YY, two hormones involved in appetite. That gives the formula a second, independent route to GLP-1, at least in principle.

A 2026 cell biology study described how butyrate signals through FFAR2 on enteroendocrine L-cells and influences the cells' identity and their release of GLP-1 and PYY (Hirdaramani et al., 2026). Butyrate is normally made in the colon when bacteria ferment fiber, which is why fiber intake and gut bacteria are closely linked to GLP-1 in research.

Adding a butyrate-producing strain is a sensible design choice. As with Akkermansia, though, the evidence is mechanistic. We found no published human trial of Clostridium butyricum WB-STR-0006 alone measuring GLP-1.

Human Akkermansia Trials Used a Different Form

The human trials most often cited for Akkermansia used a pasteurized (heat-killed) strain called MucT, made by a different company. Those trials reported less weight regain and improvements in metabolic markers in adults with excess weight. Pendulum sells live Akkermansia of its own strain, which has not been tested the same way.

A 2019 pilot study gave live or pasteurized Akkermansia daily for three months to 40 adults with excess weight; 32 completed it. Its main goals were safety and tolerability (Depommier et al., 2019). That study opened the door to larger trials, which have focused on the pasteurized form.

In a 2026 randomized trial, adults with excess weight first lost weight on a diet and then took pasteurized Akkermansia MucT or placebo for 24 weeks while eating normally. The Akkermansia group regained less weight: about 1.2 kg on average versus 3.2 kg on placebo (Mount et al., 2026).

Another 2026 trial in 142 adults in a metabolic study found that people who started with low levels of Akkermansia in their gut saw improvements after three months of pasteurized MucT, including a larger GLP-1 response after a glucose drink and less trunk fat (Suenaert et al., 2026).

These results are encouraging for Akkermansia as a category. Two cautions keep them from applying directly to Pendulum. First, pasteurized and live bacteria may work differently; in the 2019 pilot, the pasteurized form performed at least as well as live bacteria (Depommier et al., 2019), which suggests the benefit may come from surface proteins rather than living cells. Second, MucT is a different strain from WB-STR-0001. Strain differences matter in probiotic research.

Pendulum's Own Clinical Trial Tested a Different Product

Pendulum has one published placebo-controlled trial. It tested a five-strain formula, now sold as Glucose Control, a medical food meant for use under medical supervision, in a clinical population. That product contains more strains at a higher dose than the GLP-1 Probiotic.

The 2020 trial compared two experimental formulas, one with three strains and one with five, against placebo for 12 weeks. The five-strain formula improved measures of post-meal blood sugar response in that population (Perraudeau et al., 2020). Practitioner listings show the current Glucose Control product at 2 billion AFU across five strains per two-capsule serving, four times the bacterial count of the GLP-1 Probiotic.

Citing the Glucose Control trial in support of the GLP-1 Probiotic would stretch the evidence. The products differ in strains, dose, intended users and regulatory category. The trial shows Pendulum can run a credible study. It does not show this product works.

211 mg of Inulin Next to the 16 g Studied

Each capsule contains about 211 mg of chicory inulin. A study that showed prebiotics raising GLP-1 in healthy adults used 16 g a day, roughly 75 times more. At this amount, the inulin is food for the capsule's bacteria, not a meaningful dose of fiber for you.

In a small randomized trial, 10 healthy adults took 16 g a day of prebiotic fiber or a placebo for two weeks. The prebiotic group showed higher blood levels of GLP-1 and peptide YY after meals (Cani et al., 2009).

Pendulum's inulin serves a different purpose. Including a little prebiotic with a probiotic is common practice, intended to support the bacteria during transit. It is not designed to deliver the fiber dose used in GLP-1 research. If fiber is the route you are interested in, food or a fiber supplement provides grams, not milligrams. Our fiber supplement guide and Supergut review cover that approach.

The "91% Reported Reduced Cravings" Figure

Pendulum's marketing says 91% of people reported reduced overall food cravings. That figure appears to come from a customer survey rather than a placebo-controlled trial. Surveys of paying customers tend to overstate benefits, because people who expect results are more likely to notice them and respond.

Retail listings repeat the 91% figure alongside claims about maintaining a healthy weight and enhancing natural GLP-1 production. A survey result is not worthless. It tells you many customers felt something changed. It cannot separate the effect of the capsule from the effect of starting a new routine, paying for a premium product, or paying closer attention to eating.

Placebo effects on appetite and cravings are well known. That is exactly why randomized trials with a placebo group exist. Until one is published for this product, read the 91% as marketing information.

Cost and Cold Storage

At $74.99 for 30 capsules, the GLP-1 Probiotic costs about $2.50 a day at retail list price. Pendulum's own subscription pricing is often lower. Refrigeration is recommended, which matters for travel and shipping.

Live Akkermansia is expensive to make, and the price reflects that. For comparison, the practitioner version lists around $65.99. Some buyers combine the GLP-1 Probiotic with Pendulum's polyphenol product, which the company markets as food for Akkermansia, adding to the monthly cost.

Refrigeration is the practical cost. Check the bottle on arrival, especially in summer, and keep it in the fridge. If you travel, a few days at room temperature is unlikely to ruin it, but longer periods in heat will reduce live bacteria. A probiotic with dead bacteria is not necessarily useless, given the pasteurized-Akkermansia research, but it is not what you paid for.

Safety and Who Should Ask First

Akkermansia supplements were well tolerated in human trials, and the strains in this product are not known to cause serious problems in healthy adults. People with weakened immune systems, those who are pregnant or breastfeeding, and anyone taking prescription GLP-1 drugs or medication that affects blood sugar should speak with a doctor first.

The 2019 pilot made safety and tolerability its primary goals and supported further trials (Depommier et al., 2019). Larger pasteurized-Akkermansia trials in 2026 did not report major safety problems. Pendulum's labels advise pregnant or nursing women and people taking prescription drugs to consult a healthcare professional before use.

Some people notice gas or changes in bowel habits when starting any probiotic or prebiotic. These usually settle within a week or two. Taking the capsule with a meal, as the label suggests, can make the first days easier. If symptoms persist beyond a couple of weeks, stop and check with a doctor. Live probiotics are generally not recommended for people who are seriously ill or immunocompromised without medical advice.

What Changed in This Update

We rewrote this review on October 16, 2026. The earlier version described the population in Pendulum's trial in medical terms that overstated the product's purpose, used an inulin figure and price that did not match current listings, and leaned on mechanistic studies in ways that implied more human evidence than exists.

The product details now come from current retail and practitioner listings. Study descriptions follow the published abstracts. We removed a citation to an animal study that did not relate to this product and added the 2009 prebiotic trial to show the gap between the inulin in each capsule and the amount studied.

YourHealthier sells dietary supplements but not a probiotic or GLP-1 product that competes directly with this one. Pendulum had no involvement in this article.

Where the GLP-1 Probiotic Sits in Pendulum's Own Lineup

Pendulum sells Akkermansia in several strengths and blends. The single-strain Akkermansia contains 100 million AFU, Akkermansia 500 Pro contains 500 million AFU of Akkermansia alone, and the GLP-1 Probiotic splits 500 million AFU across a blend. Glucose Control, the clinical product, contains 2 billion AFU across five strains.

Product	Live bacteria per serving	Strains	Chicory inulin	Listed price seen (30 capsules)
Akkermansia	100 million AFU	Akkermansia WB-STR-0001	276 mg	$64.99 (Vitacost)
Akkermansia 500 Pro	500 million AFU	Akkermansia WB-STR-0001	276 mg	$69.99 (Vitacost)
GLP-1 Probiotic	500 million AFU (blend)	Akkermansia, C. butyricum, and in some listings B. infantis	211 mg	$74.99 (Vitacost)
Glucose Control (medical food)	2 billion AFU per 2 capsules	Five strains	207 mg	Practitioner pricing

One detail stands out. Because the GLP-1 Probiotic's 500 million AFU is shared across two or three strains, it likely contains less Akkermansia per capsule than Akkermansia 500 Pro, which puts all 500 million AFU into the one strain. The labels do not break the blend down by strain, so the exact split is unknown.

If Akkermansia is the ingredient you care about most, the single-strain products deliver it more directly and cost less. If you want the butyrate-producing strain as well, the GLP-1 Probiotic is the only consumer product in the line that combines them.

A Practical 12-Week Trial Plan

If you decide to try it, take one capsule daily with food for 12 weeks, keep the bottle refrigerated, and track two or three concrete measures, such as how often you snack, your waist measurement and how full you feel after meals. Write down a baseline in the week before you start.

The Akkermansia trials ran three to six months, and probiotics take time to establish in the gut, if they establish at all. A shorter test cannot tell you much.

Pick measures you can record honestly. Snacking frequency is easy to log in a notes app. A waist measurement once every two weeks, taken the same way each time, is more informative than daily weighing. A simple 1 to 10 rating of fullness after lunch adds a subjective check.

Keep other things steady where you can. Starting a new diet, a new exercise plan and a new probiotic in the same week makes it impossible to tell which one made the difference.

At 12 weeks, compare your notes with the baseline. If nothing has changed, you have spent about $225 to learn that this product does not do much for you, which is useful information. If something has changed, you can decide whether the effect is worth $75 a month.

Questions Worth Asking Pendulum

Ask how much of the 500 million AFU is Akkermansia, whether the current consumer formula includes Bifidobacterium infantis, how viability is guaranteed through the expiration date, and whether a trial of this product is planned. Clear answers would tell you more than marketing copy can.

Strain breakdown. The label lists a combined count. Knowing how many Akkermansia cells are in each capsule would make it easier to compare with the single-strain products and with research doses.

Current formula. Different listings show two or three strains and different inulin amounts. Ask which applies to the lot you will receive.

Viability at expiry. Probiotic counts are often stated at manufacture. Ask whether 500 million AFU is guaranteed at the end of shelf life under recommended storage.

Trials. Ask whether Pendulum is running or planning a placebo-controlled trial of the GLP-1 Probiotic itself. The company has run a trial before, so it has the capacity.

Live or Pasteurized: Does It Matter?

Possibly less than the marketing suggests. Researchers think some of Akkermansia's effects come from proteins on its surface, such as Amuc_1100, and from secreted proteins such as P9, which do not require living cells. That would help explain why heat-killed Akkermansia produced results in human trials.

Pendulum emphasizes that its Akkermansia is alive, and producing live anaerobic bacteria at scale is hard. The research picture is more mixed than "live is better." Pasteurization kills the bacteria but leaves many of their proteins intact. If those proteins drive the effect on the gut lining and on L-cells, then a well-made pasteurized product could deliver similar benefits, with easier storage.

Live bacteria could still offer something extra if they settle in the gut and keep producing helpful compounds. Whether Pendulum's strain does that in people, and for how long after you stop taking it, has not been published. For now, the fair comparison is between a live product with mechanistic support and pasteurized products with human trial support, from different companies and different strains.

How It Fits With the Rest of Your Diet

A probiotic adds bacteria. Food decides what those bacteria have to eat. A diet low in fiber and plant foods gives Akkermansia and butyrate producers less to work with, so a capsule is unlikely to make up for meals that lack them.

Butyrate, the compound behind the Clostridium butyricum rationale, is made when gut bacteria ferment fiber. Most of the fiber that feeds this process comes from vegetables, legumes, whole grains, fruit and nuts. The 211 mg of inulin in each capsule is a token amount next to the grams that food provides.

Protein and fat in a meal also prompt L-cells to release GLP-1. Building meals around protein, fiber and vegetables works on the same hormone this product targets, at no extra cost. Our guide to natural ways to support GLP-1 covers this in more detail.

Pendulum GLP-1 Probiotic FAQ

Quick answers on what is in the capsule, the evidence, cost and storage, based on current listings and the studies above.

What strains are in Pendulum GLP-1 Probiotic?

Akkermansia muciniphila WB-STR-0001 and Clostridium butyricum WB-STR-0006 at a combined 500 million AFU, plus chicory inulin. Some listings, including the practitioner version, also list Bifidobacterium infantis.

Has Pendulum GLP-1 Probiotic been clinically tested?

Not in a published trial. Pendulum's published trial tested a different five-strain product (Perraudeau et al., 2020), and the larger human Akkermansia trials used a pasteurized strain from another company.

Does it contain GLP-1?

No. It contains bacteria that, in lab and animal research, prompted the gut to release its own GLP-1. It is not a GLP-1 drug.

Do I need to refrigerate it?

Practitioner labels say to refrigerate for optimal quality. Keep it cold to protect the live bacteria.

How long before I notice anything?

The human Akkermansia trials ran three to six months. Give any probiotic at least eight to twelve weeks of daily use before judging it.

What does AFU mean?

Active fluorescent units. Pendulum counts bacteria by staining them and measuring them with flow cytometry rather than by growing them on plates, which is how CFU are counted. The two numbers cannot be compared directly.

Should I take it with food?

The practitioner labels say to take one capsule daily with food. Taking it at the same meal each day also makes it easier to remember, which matters for a 12-week trial.

Is it vegetarian?

The capsule is listed as hypromellose, a vegetarian material. Other listed ingredients are microcrystalline cellulose and silica, with some versions adding L-leucine or medium-chain triglycerides.

Can I take it with a prescription GLP-1 drug?

Ask your prescriber first. No study has tested this product alongside GLP-1 medications, and there is no evidence it adds to their effect.

Where can I read about other GLP-1 support products?

See our Lemme GLP-1 Daily review, our guide to natural ways to support GLP-1, and best probiotics for gut health.